Background: Bariatric surgery is the most effective long-term treatment of severe obesity. Unfortunately, many patients experience inadequate weight loss, weight plateau, or weight recidivism. We sought to determine the efficacy of high-dose liraglutide (3.
View Article and Find Full Text PDFLiraglutide is a glucagon-like peptide type 1 (GLP-1) analogue that is approved for long-term obesity management in North America. While bariatric surgery remains the gold standard for weight loss, an increasing number of patients are on liraglutide in the setting of ongoing workup for bariatric surgery. The presence of gastrointestinal symptoms prior to bariatric surgery may prompt testing for dysmotility, which affects surgical decision making.
View Article and Find Full Text PDFBackground: Home enteral nutrition (HEN) is a life-sustaining therapy for patients who are unable to meet nutrient needs by oral intake, who have a functional gastrointestinal (GI) tract, and who are able to remain in their own home. The objective of this study was to identify whether the indication for HEN is related to reason for discharge from a HEN program.
Methods: A retrospective chart review of all patients admitted to the multidisciplinary Northern Alberta Home Enteral Nutrition Support Program between January 1, 1999 and January 1, 2005 was performed.